FDA NDC Directory · JSON-LD · Markdown

Trazimera

NDC 0069-0308 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nametrastuzumab-qyyp
Labeler / ManufacturerPfizer Laboratories Div Pfizer Inc
Marketing categoryBiologic License Application · App BLA761081
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsTRASTUZUMAB (150 mg/7.15mL)
Marketing started20210310
Package count1

External sources

Source: openFDA. Public-domain (CC0).